US Stock MarketDetailed Quotes

Cytosorbents (CTSO)

Watchlist
  • 0.6600
  • +0.0500+8.20%
Close Apr 17 16:00 ET
  • 0.6400
  • -0.0200-3.03%
Post 20:01 ET
41.45MMarket Cap-5.08P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cytosorbents (CTSO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
4.12%37.06M
0.91%9.23M
10.12%9.49M
8.76%9.62M
-2.92%8.73M
14.51%35.6M
24.53%9.15M
11.08%8.61M
9.53%8.84M
13.65%8.99M
Operating revenue
4.12%37.06M
0.91%9.23M
10.12%9.49M
8.76%9.62M
-2.92%8.73M
14.51%35.6M
24.53%9.15M
11.08%8.61M
9.53%8.84M
13.65%8.99M
Cost of revenue
-1.27%10.57M
-16.09%2.43M
-16.03%2.82M
19.84%2.8M
19.08%2.52M
17.26%10.71M
297.18%2.9M
4.78%3.36M
-31.25%2.34M
-47.03%2.12M
Gross profit
6.45%26.49M
8.78%6.8M
26.83%6.67M
4.78%6.81M
-9.69%6.21M
13.36%24.89M
-29.06%6.26M
15.52%5.26M
39.25%6.5M
75.53%6.87M
Operating expense
-1.47%40.73M
10.66%10.68M
-5.53%9.53M
3.53%10.43M
-12.45%10.09M
-23.31%41.34M
-48.94%9.65M
-15.25%10.09M
-10.30%10.07M
-2.35%11.53M
Selling and administrative expenses
5.67%35.65M
23.59%9.44M
4.24%8.61M
7.17%9.17M
-9.17%8.43M
-11.94%33.73M
-30.54%7.64M
-10.29%8.26M
-3.98%8.55M
1.65%9.28M
-General and administrative expense
----
----
----
----
----
----
----
-15.00%7.83M
-5.69%8.4M
1.26%9.25M
Research and development costs
-33.15%5.09M
-38.31%1.24M
-49.73%918K
-16.92%1.26M
-25.99%1.66M
-51.22%7.61M
-49.14%2.02M
-51.30%1.83M
-58.60%1.52M
-46.69%2.25M
Other operating expenses
----
----
----
----
----
----
----
26.42%-777.59K
21.92%-1.05M
48.24%-796.77K
Operating profit
13.45%-14.24M
-14.14%-3.88M
40.75%-2.86M
-1.26%-3.62M
16.52%-3.89M
48.50%-16.45M
66.32%-3.4M
34.29%-4.83M
45.57%-3.57M
41.00%-4.66M
Net non-operating interest income expense
-86.70%-2.61M
-19.55%-746K
-9.69%-645K
-242.22%-616K
-8,995.66%-605.13K
-786.05%-1.4M
-1,094.74%-624K
-1,646.36%-588K
-1,940.58%-180K
89.47%-6.65K
Non-operating interest expense
86.70%2.61M
19.55%746K
9.69%645K
242.22%616K
8,995.66%605.13K
786.05%1.4M
1,094.74%624K
1,646.36%588K
--180K
--6.65K
Total other finance cost
----
----
----
----
----
----
----
----
1,941.70%180.1K
-89.47%6.65K
Other net income (expense)
281.00%8.25M
83.28%-876K
-102.42%-64K
1,235.66%6.18M
311.41%3.01M
-322.82%-4.56M
-290.86%-5.24M
246.44%2.65M
-231.09%-544K
-326.70%-1.43M
Gain on sale of security
320.62%9.32M
103.93%193K
-102.42%-64K
1,235.66%6.18M
311.41%3.01M
-316.75%-4.23M
-282.80%-4.91M
246.44%2.65M
-231.09%-544K
-315.79%-1.43M
Special income (charges)
---510K
----
----
----
----
--0
----
----
----
----
-Less：Restructuring and merger&acquisition
--510K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-67.37%-559K
----
----
----
----
-445.20%-334K
----
----
----
----
Income before tax
61.63%-8.6M
40.62%-5.5M
-29.01%-3.57M
145.34%1.95M
75.72%-1.48M
25.45%-22.41M
-25.31%-9.26M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
Income tax
76.29%-401K
0
-401K
0
-107.81%-1.69M
-107.81%-1.69M
0
0
0
Net income
60.43%-8.2M
27.36%-5.5M
-14.52%-3.17M
145.34%1.95M
75.72%-1.48M
29.16%-20.72M
-15.10%-7.57M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
Net income continuous Operations
60.43%-8.2M
27.36%-5.5M
-14.52%-3.17M
145.34%1.95M
75.72%-1.48M
29.16%-20.72M
-15.10%-7.57M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
Minority interest income
Net income attributable to the parent company
60.43%-8.2M
27.36%-5.5M
-14.52%-3.17M
145.34%1.95M
75.72%-1.48M
29.16%-20.72M
-15.10%-7.57M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
60.43%-8.2M
27.36%-5.5M
-14.52%-3.17M
145.34%1.95M
75.72%-1.48M
29.16%-20.72M
-15.10%-7.57M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
Basic earnings per share
65.79%-0.13
35.71%-0.09
0.00%-0.05
137.50%0.03
81.82%-0.02
41.54%-0.38
-5.60%-0.14
76.07%-0.05
42.57%-0.08
34.97%-0.11
Diluted earnings per share
65.79%-0.13
35.71%-0.09
0.00%-0.05
137.50%0.03
81.82%-0.02
41.54%-0.38
-5.60%-0.14
76.07%-0.05
42.57%-0.08
34.97%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 4.12%37.06M0.91%9.23M10.12%9.49M8.76%9.62M-2.92%8.73M14.51%35.6M24.53%9.15M11.08%8.61M9.53%8.84M13.65%8.99M
Operating revenue 4.12%37.06M0.91%9.23M10.12%9.49M8.76%9.62M-2.92%8.73M14.51%35.6M24.53%9.15M11.08%8.61M9.53%8.84M13.65%8.99M
Cost of revenue -1.27%10.57M-16.09%2.43M-16.03%2.82M19.84%2.8M19.08%2.52M17.26%10.71M297.18%2.9M4.78%3.36M-31.25%2.34M-47.03%2.12M
Gross profit 6.45%26.49M8.78%6.8M26.83%6.67M4.78%6.81M-9.69%6.21M13.36%24.89M-29.06%6.26M15.52%5.26M39.25%6.5M75.53%6.87M
Operating expense -1.47%40.73M10.66%10.68M-5.53%9.53M3.53%10.43M-12.45%10.09M-23.31%41.34M-48.94%9.65M-15.25%10.09M-10.30%10.07M-2.35%11.53M
Selling and administrative expenses 5.67%35.65M23.59%9.44M4.24%8.61M7.17%9.17M-9.17%8.43M-11.94%33.73M-30.54%7.64M-10.29%8.26M-3.98%8.55M1.65%9.28M
-General and administrative expense -----------------------------15.00%7.83M-5.69%8.4M1.26%9.25M
Research and development costs -33.15%5.09M-38.31%1.24M-49.73%918K-16.92%1.26M-25.99%1.66M-51.22%7.61M-49.14%2.02M-51.30%1.83M-58.60%1.52M-46.69%2.25M
Other operating expenses ----------------------------26.42%-777.59K21.92%-1.05M48.24%-796.77K
Operating profit 13.45%-14.24M-14.14%-3.88M40.75%-2.86M-1.26%-3.62M16.52%-3.89M48.50%-16.45M66.32%-3.4M34.29%-4.83M45.57%-3.57M41.00%-4.66M
Net non-operating interest income expense -86.70%-2.61M-19.55%-746K-9.69%-645K-242.22%-616K-8,995.66%-605.13K-786.05%-1.4M-1,094.74%-624K-1,646.36%-588K-1,940.58%-180K89.47%-6.65K
Non-operating interest expense 86.70%2.61M19.55%746K9.69%645K242.22%616K8,995.66%605.13K786.05%1.4M1,094.74%624K1,646.36%588K--180K--6.65K
Total other finance cost --------------------------------1,941.70%180.1K-89.47%6.65K
Other net income (expense) 281.00%8.25M83.28%-876K-102.42%-64K1,235.66%6.18M311.41%3.01M-322.82%-4.56M-290.86%-5.24M246.44%2.65M-231.09%-544K-326.70%-1.43M
Gain on sale of security 320.62%9.32M103.93%193K-102.42%-64K1,235.66%6.18M311.41%3.01M-316.75%-4.23M-282.80%-4.91M246.44%2.65M-231.09%-544K-315.79%-1.43M
Special income (charges) ---510K------------------0----------------
-Less：Restructuring and merger&acquisition --510K------------------0----------------
Other non- operating income (expenses) -67.37%-559K-----------------445.20%-334K----------------
Income before tax 61.63%-8.6M40.62%-5.5M-29.01%-3.57M145.34%1.95M75.72%-1.48M25.45%-22.41M-25.31%-9.26M69.89%-2.77M30.21%-4.29M16.89%-6.09M
Income tax 76.29%-401K0-401K0-107.81%-1.69M-107.81%-1.69M000
Net income 60.43%-8.2M27.36%-5.5M-14.52%-3.17M145.34%1.95M75.72%-1.48M29.16%-20.72M-15.10%-7.57M69.89%-2.77M30.21%-4.29M16.89%-6.09M
Net income continuous Operations 60.43%-8.2M27.36%-5.5M-14.52%-3.17M145.34%1.95M75.72%-1.48M29.16%-20.72M-15.10%-7.57M69.89%-2.77M30.21%-4.29M16.89%-6.09M
Minority interest income
Net income attributable to the parent company 60.43%-8.2M27.36%-5.5M-14.52%-3.17M145.34%1.95M75.72%-1.48M29.16%-20.72M-15.10%-7.57M69.89%-2.77M30.21%-4.29M16.89%-6.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 60.43%-8.2M27.36%-5.5M-14.52%-3.17M145.34%1.95M75.72%-1.48M29.16%-20.72M-15.10%-7.57M69.89%-2.77M30.21%-4.29M16.89%-6.09M
Basic earnings per share 65.79%-0.1335.71%-0.090.00%-0.05137.50%0.0381.82%-0.0241.54%-0.38-5.60%-0.1476.07%-0.0542.57%-0.0834.97%-0.11
Diluted earnings per share 65.79%-0.1335.71%-0.090.00%-0.05137.50%0.0381.82%-0.0241.54%-0.38-5.60%-0.1476.07%-0.0542.57%-0.0834.97%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -